Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise for treating various skin diseases.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Non-drug therapies show promise for hair regrowth but need more research.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Machine learning and deep learning can effectively diagnose alopecia areata.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.